DR. D KALIDOSS,LUKESHWARI SAHU,DR. MONICA VERMA
DOI: https://doi.org/When it comes to treating infectious disorders, the ability to send nanoparticles straight into the targeted cells is crucial. The potential for a medicinal ingredient to be chemically bonded to the nanoparticles has opened up a new avenue for medication delivery. Remarkably, the discovery of graphene and carbon nanotubes has provided a superior therapeutic and imaging agent for use in biomedical applications. Pharmaceutical drug delivery technologies like liquid crystals, vesicles, and micelles have been developed for decades, but their use has been restricted because of their high manufacturing costs.
